A carregar...

Toxicity of Immune Checkpoint Inhibitors: Considerations for the Surgeon

BACKGROUND. The use of immunotherapeutic agents, specifically immune checkpoint inhibitors (ICIs) for solid malignancies, is rapidly rising, and many new agents and treatment combinations are in development. However, ICIs have a unique side-effect profile of immune-related adverse events (irAEs) com...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Surg Oncol
Main Authors: Helmink, Beth A., Roland, Christina L., Kiernan, Colleen M., Wargo, Jennifer A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7594106/
https://ncbi.nlm.nih.gov/pubmed/31965370
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-019-08183-0
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!